Healthcare provider profile · identity verified

Samuel E Heck, DO

Family Practice · WICHITA, KS · NPI 1346207370

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	310	84
Levothyroxine Sodium	Levothyroxine Sodium	185	45
Meloxicam	Meloxicam	178	44
Pantoprazole Sodium	Pantoprazole Sodium	170	37
Losartan Potassium	Losartan Potassium	166	43
Amlodipine Besylate	Amlodipine Besylate	162	45
Omeprazole	Omeprazole	152	39
Metformin Hcl Er	Metformin Hcl	141	35
Lisinopril	Lisinopril	135	40
Simvastatin	Simvastatin	126	29
Fluticasone Propionate	Fluticasone Propionate	123	58
Furosemide	Furosemide	115	33
Rosuvastatin Calcium	Rosuvastatin Calcium	115	31
Tamsulosin Hcl	Tamsulosin Hcl	108	25
Citalopram Hbr	Citalopram Hydrobromide	100	21
Eliquis	Apixaban	99	17
Duloxetine Hcl	Duloxetine Hcl	88	16
Glipizide Er	Glipizide	88	22
Metoprolol Succinate	Metoprolol Succinate	87	27
Potassium Chloride	Potassium Chloride	86	21
Gabapentin	Gabapentin	85	22
Allopurinol	Allopurinol	78	21
Famotidine	Famotidine	77	22
Amitriptyline Hcl	Amitriptyline Hcl	67	14
Metformin Hcl	Metformin Hcl	64	14
Albuterol Sulfate Hfa	Albuterol Sulfate	62	26
Diazepam	Diazepam	61	suppressed
Trazodone Hcl	Trazodone Hcl	54	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	53	14
Escitalopram Oxalate	Escitalopram Oxalate	52	16
Metoprolol Tartrate	Metoprolol Tartrate	52	17
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Alprazolam	Alprazolam	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	15
Clopidogrel	Clopidogrel Bisulfate	45	12
Jardiance	Empagliflozin	44	suppressed
Montelukast Sodium	Montelukast Sodium	44	12
Pravastatin Sodium	Pravastatin Sodium	44	11
Pregabalin	Pregabalin	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	15
Azithromycin	Azithromycin	39	33
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Sucralfate	Sucralfate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	13
Warfarin Sodium	Warfarin Sodium	32	suppressed
Estradiol	Estradiol	31	suppressed
Lovastatin	Lovastatin	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Celecoxib	Celecoxib	28	13
Clonazepam	Clonazepam	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Ibuprofen	Ibuprofen	27	15
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Atenolol	Atenolol	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	11
Fluconazole	Fluconazole	25	16
Methocarbamol	Methocarbamol	25	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Mupirocin	Mupirocin	23	14
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Primidone	Primidone	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Linzess	Linaclotide	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	11
Farxiga	Dapagliflozin Propanediol	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	12
Nystatin	Nystatin	18	11
Famciclovir	Famciclovir	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Verapamil Er	Verapamil Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cefprozil	Cefprozil	16	16
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	12
Lorazepam	Lorazepam	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Glipizide	Glipizide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Belsomra	Suvorexant	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Temazepam	Temazepam	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error